126 related articles for article (PubMed ID: 33423300)
1. Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation.
Pan JW; Zabidi MMA; Chong BK; Meng MY; Ng PS; Hasan SN; Sandey B; Bahnu S; Rajadurai P; Yip CH; Rueda OM; Caldas C; Chin SF; Teo SH
Int J Cancer; 2021 May; 148(10):2489-2501. PubMed ID: 33423300
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of APOBEC3A and 3B expression in patients with breast cancer.
Kim YS; Sun S; Yoon JS; Ko YH; Won HS; Kim JS
PLoS One; 2020; 15(3):e0230261. PubMed ID: 32176735
[TBL] [Abstract][Full Text] [Related]
3. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
[TBL] [Abstract][Full Text] [Related]
4. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection.
Abe H; Ochi H; Maekawa T; Hatakeyama T; Tsuge M; Kitamura S; Kimura T; Miki D; Mitsui F; Hiraga N; Imamura M; Fujimoto Y; Takahashi S; Nakamura Y; Kumada H; Chayama K
Hepatol Res; 2009 Dec; 39(12):1159-68. PubMed ID: 19788695
[TBL] [Abstract][Full Text] [Related]
5. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Cescon DW; Haibe-Kains B; Mak TW
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers.
Tsuboi M; Yamane A; Horiguchi J; Yokobori T; Kawabata-Iwakawa R; Yoshiyama S; Rokudai S; Odawara H; Tokiniwa H; Oyama T; Takeyoshi I; Nishiyama M
Breast Cancer; 2016 Sep; 23(5):780-8. PubMed ID: 26476745
[TBL] [Abstract][Full Text] [Related]
8. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
Chen Z; Wen W; Bao J; Kuhs KL; Cai Q; Long J; Shu XO; Zheng W; Guo X
BMC Med Genomics; 2019 Sep; 12(1):131. PubMed ID: 31533728
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
bioRxiv; 2023 Aug; ():. PubMed ID: 37577595
[TBL] [Abstract][Full Text] [Related]
11. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
[TBL] [Abstract][Full Text] [Related]
12. Genetic inhibitors of APOBEC3B-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
14. APOBEC shapes tumor evolution and age at onset of lung cancer in smokers.
Zhang T; Sang J; Hoang PH; Zhao W; Rosenbaum J; Johnson KE; Klimczak LJ; McElderry J; Klein A; Wirth C; Bergstrom EN; Díaz-Gay M; Vangara R; Colon-Matos F; Hutchinson A; Lawrence SM; Cole N; Zhu B; Przytycka TM; Shi J; Caporaso NE; Homer R; Pesatori AC; Consonni D; Imielinski M; Chanock SJ; Wedge DC; Gordenin DA; Alexandrov LB; Harris RS; Landi MT
bioRxiv; 2024 Apr; ():. PubMed ID: 38617360
[TBL] [Abstract][Full Text] [Related]
15. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
Udquim KI; Zettelmeyer C; Banday AR; Lin SH; Prokunina-Olsson L
Carcinogenesis; 2020 Aug; 41(8):1030-1037. PubMed ID: 31930332
[TBL] [Abstract][Full Text] [Related]
17. The 30 kb deletion in the
Klonowska K; Kluzniak W; Rusak B; Jakubowska A; Ratajska M; Krawczynska N; Vasilevska D; Czubak K; Wojciechowska M; Cybulski C; Lubinski J; Kozlowski P
Oncotarget; 2017 Sep; 8(44):76357-76374. PubMed ID: 29100317
[No Abstract] [Full Text] [Related]
18. Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p.
Faure-Dupuy S; Riedl T; Rolland M; Hizir Z; Reisinger F; Neuhaus K; Schuehle S; Remouchamps C; Gillet N; Schönung M; Stadler M; Wettengel J; Barnault R; Parent R; Schuster LC; Farhat R; Prokosch S; Leuchtenberger C; Öllinger R; Engleitner T; Rippe K; Rad R; Unger K; Tscharahganeh D; Lipka DB; Protzer U; Durantel D; Lucifora J; Dejardin E; Heikenwälder M
JHEP Rep; 2021 Dec; 3(6):100354. PubMed ID: 34704004
[TBL] [Abstract][Full Text] [Related]
19. Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma.
Zhang T; Cai J; Chang J; Yu D; Wu C; Yan T; Zhai K; Bi X; Zhao H; Xu J; Tan W; Qu C; Lin D
Hum Mol Genet; 2013 Mar; 22(6):1262-9. PubMed ID: 23213177
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifiers of APOBEC-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Bray N; Mitchell D; Lobachev K; Roberts SA
bioRxiv; 2023 Apr; ():. PubMed ID: 37066362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
